 |
 |
 |
|
|
|
|
 |
Pharmaceutical Stability Testing (2004)
|
|
|
|
 |
|
The 2004 Pharma Stability Testing Conference is this year's "must attend" event.
Meet the Regulators - we are lucky enough to have the UK's Medicines & Healthcare Products Regulatory Agency, and two ex-FDA officials on hand to really give you the insiders view on getting your stability testing right.
Big Pharma Experience - this year you have a unique opportunity to learn from the leading stability testing experts in each of the following big pharma companies:
PfizerAventisAbbott LabsMerckSanofi-SynthelaboAstraZenecaBaxter Healthcare
What you will learn at this major event: how to -
1) Establish a practical stability programme from ground zero
2) Comply with the latest ICH and SPMP stability guidelines
3) Meet new FDA requirements
4) Address the key stability issues at each stage in the drug development process
5) Develop best practice analytical methods
6) Prevent and overcome common stability problems
7) Assess the financial effects of stability problems
Who will you meet at this event - Previous attendees include:
3M Healthcare, Abbott, Allergan, Amersham Biosciences, Amgen, AstraZeneca, Aventis, Bayer, Biogen I'dec, Boehringer Ingelheim, Bristol-Myers Squibb, Celltech, Covance, Elan Pharma, Eli Lilly, F Hoffmann-La Roche, GlaxoSmithKline, Lundbeck, Janssen, Johnson & Johnson, Karo Bio, KMI/Parexel, Knoll Pharmaceuticals, Merck & Co, Merck KGaA, Merck Sharp & Dohme, Millennium Pharmaceuticals, Novartis, Novo Nordisk, Ortho Biotech, Pfizer, Pharmacia & Upjohn, Pliva, Procter & Gamble, Quintiles, Roche, Sanofi Synthelabo, Schering AG, Serona, Wyeth and many more.
Practical tools and techniques:
You will learn how to set up programmes, compile checklists, develop systems, set up training programmes, validate methods and much more...
Plus...
Why the best stabilisation offence is defence Briefing on the latest regulation from the MHRA Update from two ex-FDA officials Real world examples and casestudies from industry insiders Best practice casestudies on desiging your stability tests Lessons from Merck and Intercell on stability testing in vaccine development
Learn from the international experts:
Pfizer are presenting two key sessions on: how to assess the impact of formulation variables on chemical stability how to evaluate data in accordance with Q1E
Plus, Abbott Laboratories are presenting two key sessions on: how to design and evaluate tests for early R&D stability how intermediate processing can impact purity and stability
Plus, case studies from Quintiles, Baxter, Aventis, Intercell, Lonza, Abbott, Merck, Pfizer, Sanofi, AstraZeneca, Pharmalytica and Millennium
|
|
|
 |
|
|
|
|
 |
|
|
|
|
Pharmaceutical Stability Testing, Conference Documentation - Hard Copy Documentation, Single User License
|
|
£499.00 |
 |
|
|
Pharmaceutical Stability Testing, Conference Documentation - PDF Documentation on CD ROM, Single User License
|
|
£499.00 |
|
|
|
Pharmaceutical Stability Testing, Conference Documentation - PDF Documentation on CD ROM with Audio, Single User License
|
|
£699.00 |
|
|
|
Pharmaceutical Stability Testing, Conference Documentation - PDF Documentation on CD ROM, Site License
|
|
£1,497.00 |
|
|
|
Pharmaceutical Stability Testing, Conference Documentation - PDF Documentation on CD ROM with Audio, Site License
|
|
£2,097.00 |
|
|
|
|
|
|
 |
|
 |
|
Events Home Page
